Oyogist has learned that an antiviral pill for high risk COVID-19 patients will be rolled out in UK from next month, the government has announced.
The Department of Health and Social Care (DHSC) said the UK’s second antiviral, PF-07321332+ritonavir, will be made available to thousands of people with weakened immune systems from 10 February in a bid to save lives.
Clinical studies also reveals that the drug, which is made by Pfizer and also known as Paxlovid, can cut the risk of hospital admission or death by 88% if given in the first five days of symptoms.
It is especially important for people with weakened immune systems who may not get maximum protection from vaccines.
